Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26709-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- BSAP,PAX5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated BSAP,PAX5 antibody (Cat. #26709-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A single microRNA miR-195 rescues the arrested B cell development induced by EBF1 deficiency.
Inhibition of HMGN2 SUMOylation ameliorates atherosclerosis by activating PAX5 expression to induce macrophage M2 polarization.
Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5.
Prohibitin 2 confers NADPH oxidase 1-mediated cytosolic oxidative signaling to promote gastric cancer progression by ERK activation.
miR-126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis-associated colorectal cancer.
Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis.
Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Miyatake Y, Kamakura T, Ikawa T, Yanagiya R, Kotaki R, Kameda K, Nasu RK, Okuyama K, Hirano KI, Hosokawa H, Hozumi K, Ohtsuka M, Kisikawa T, Shibata C, Otsuka M, Maruyama R, Ando K, Kurosaki T, Kawamoto H, Kotani A
eLife 2026 Feb 6;13
eLife 2026 Feb 6;13
Inhibition of HMGN2 SUMOylation ameliorates atherosclerosis by activating PAX5 expression to induce macrophage M2 polarization.
Wang X, Wu P, Shen Y, Xu S, Wan Q, Yang Y
Experimental cell research 2025 Aug 15;451(2):114709
Experimental cell research 2025 Aug 15;451(2):114709
Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5.
Zhang X, Ma C, Lu Y, Wang J, Yun H, Jiang H, Wu M, Feng X, Gai W, Xu G, Deng H, Feng J, Liu W, Shi T, Cheng Q, Zhang J
Cellular & molecular immunology 2024 Nov;21(11):1282-1295
Cellular & molecular immunology 2024 Nov;21(11):1282-1295
Prohibitin 2 confers NADPH oxidase 1-mediated cytosolic oxidative signaling to promote gastric cancer progression by ERK activation.
Xu L, Meng L, Xiang W, Wang X, Yang J, Shu C, Zhao XH, Rong Z, Ye Y
Free radical biology & medicine 2024 Nov 1;224:130-143
Free radical biology & medicine 2024 Nov 1;224:130-143
miR-126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis-associated colorectal cancer.
Wu S, Yuan W, Luo W, Nie K, Wu X, Meng X, Shen Z, Wang X
Molecular oncology 2022 Oct;16(19):3465-3489
Molecular oncology 2022 Oct;16(19):3465-3489
Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis.
Huang R, Zeng Z, Yan P, Yin H, Zhu X, Hu P, Zhuang J, Li J, Li S, Song D, Meng T, Huang Z
Cancer cell international 2021 Jan 4;21(1):3
Cancer cell international 2021 Jan 4;21(1):3
Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS, Marusic Z, Azzato EM, Farkas DH, Van Arnam J, Seiwerth S, Fritchie K, Patel RM, Rubin BP, Billings SD
Journal of cutaneous pathology 2020 Jun;47(6):509-516
Journal of cutaneous pathology 2020 Jun;47(6):509-516
No comments: Submit comment
No validations: Submit validation data